Abiraterone acetate for treatment of ectopic Cushing syndrome caused by ACTH-producing neuroendocrine tumor: a case report

BACKGROUND: Ectopic Cushing syndrome (EAS) secondary to an adrenocorticotropin hormone (ACTH)-releasing neuroendocrine tumor (NET) is a rare diagnosis that can be resistant to standard treatments. Abiraterone acetate (AA) is a selective and irreversible inhibitor of 17α-hydroxylase/17,20-lyase that...

Descripción completa

Detalles Bibliográficos
Autores principales: Chacko, Rebecca, Abdel-Razeq, Nayef Hikmat, Abu Rous, Fawzi, Loutfi, Randa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660030/
https://www.ncbi.nlm.nih.gov/pubmed/36388644
http://dx.doi.org/10.21037/jgo-22-376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660030/
https://www.ncbi.nlm.nih.gov/pubmed/36388644
http://dx.doi.org/10.21037/jgo-22-376

Ejemplares similares